Substantial disparities in the incidence, prognosis, and immune response between men and women become evident in the context of acute infectious diseases. Clinical studies have consistently demonstrated a higher incidence of bacteremic infections among men, including conditions such as invasive pneumococcal disease (10), Pseudomonas aeruginosa (11), or Staphylococcus aureus (12) infections. When these infections progress toward sepsis, the male sex emerges as a significant risk factor, as higher mortality and sequelae are reported in men (12–15). In a large cohort including more than 10 million cases of sepsis, the male sex was associated with a higher incidence (16). Similarly, men admitted to intensive care units (ICUs) exhibit a heightened incidence of sepsis and shock (17). Despite these findings suggesting that the male sex is linked to an elevated risk of bacteremic infections, it is important to note that the incidence of Escherichia coli bacteremia is higher in women (18, 19). This observation, however, can be attributed to anatomical differences of the urinary tract, where E. coli urinary tract infections (UTI) predominate in women. Nevertheless, men face a greater risk of morbidity (20, 21) and mortality (22) from the complications of UTIs and require more extended treatment to eliminate the bacterial infection (23).

Sex differences are also evident in bacterial lung infections. The male sex is a risk factor in the context of community-acquired pneumonia (CAP) (24–27). Men not only experience a more unfavorable disease progression, but also exhibit a higher rate of admissions to ICUs (26, 27). The most common pathogen isolated in CAP is Streptococcus pneumoniae (28), with men being disproportionately affected by severe pneumococcal CAP (29). Tuberculosis, another prominent bacterial infection with a global impact on patient mortality, also displays sex-based disparities. Mycobacterium tuberculosis primarily afflicts men, who concurrently manifest elevated mortality rates compared with women (30, 31).

These clinical observations align with corresponding biological findings observed in sepsis and other infectious diseases. An investigation involving prepubertal children admitted to ICUs for sepsis revealed higher maximum white blood cell and neutrophil counts, lower pH, and higher C-reactive protein (CRP) levels in women (32). In the early stages of the disease, general biological markers of inflammation are more elevated in women, indicating a heightened activation of innate defense mechanisms. However, over time, a distinct kinetic pattern emerges, highlighting differences in the return to homeostasis between women and men. In contrast to these general inflammatory markers, levels of proinflammatory cytokines such as interleukin 1β (IL-1β), IL-6, and tumor necrosis factor alpha (TNF-α) are higher in men, whereas women exhibit elevated levels of anti-inflammatory mediators, notably IL-10 (13, 33). Men with CAP, who face a worse prognostic compared with women with CAP, present stronger release of TNF-α (34).

Findings from studies involving human subjects are congruent with observations in animal models. In an experimental model of sepsis induced by cecal ligation, female mice exhibit higher survival rates and maintain splenocyte functions (35), whereas male mice release higher levels of IL-6, TNF-α, and prostaglandin E2 (PGE2) (36). Among mice, there is a heightened incidence of systemic pneumococcal infection and pneumococcal respiratory infection in males, who also present higher mortality rates than their female counterparts (37). Further, male mice infected with S. pneumoniae produce significantly greater quantities of proinflammatory cytokines, including IL-6, IL-12p70, interferon gamma (IFN-γ), granulocyte colony-stimulating factor (G-CSF), and IL-17A (37). Mycobacterium bovis, which causes bovine tuberculosis, and Mycoplasma pulmonis, responsible for respiratory mycoplasmosis in mice, both display a more severe clinical outcome and higher mortality in males (31). Interestingly, M. pulmonis induces alveolar neutrophil infiltrate with edema and hemorrhage in males, resembling an acute alveolar inflammatory response. Conversely, female lungs with respiratory mycoplasmosis display macrophage infiltration with minimal neutrophils, akin to a chronic peribronchial inflammatory response (31).

Sex disparities in bacterial infections extend beyond mammals, with documented differences in defense against pathogens observed in insects and birds (38, 39).

Sexual dimorphism in clinical outcomes and immune responses is notably evident in viral infections. Throughout the COVID-19 pandemic, epidemiological reports have consistently described a better clinical course in women (4–7), with men presenting higher levels of proinflammatory cytokines (40). Similarly, during the outbreaks of severe acute respiratory syndrome (SARS-CoV) and Middle East respiratory syndrome (MERS-CoV), men showed a higher incidence and more severe disease (41, 42). Sex disparities are also apparent in Paramyxoviridae infections; boys infected with respiratory syncytial virus (RSV) or human metapneumovirus (hMPV) develop more severe clinical manifestations compared with girls (43–45).

Dengue virus (DENV) a substantial global health concern, also displays sex differences, with men experiencing a disadvantage (46).

In contrast to the aforementioned viruses, among adults infected with influenza A, women are more susceptible to an increased risk of severe clinical presentations (47), accompanied by higher IFN-γ levels compared with men (44, 48, 49).

Sex-specific disparities in viral responses have been corroborated in animal models. Male golden Syrian hamster exhibit a poorer outcome and develop more severe SARS-CoV-2 pneumonia than their female counterparts (50) and male mice infected with RSV display impaired IFN-β expression and viral control (51). Female mice infected with equal viral loads of influenza virus to males, experience a worse outcome, with greater cytokine and chemokine release in their lungs (44, 52).

Sex-specific patterns in complication rates are evident among trauma patients. As reported by Mörs et al. (53), men exhibit higher injury scores and an increased risk of developing sepsis following trauma. In polytraumatized patients, men have a higher incidence of multiple organ dysfunction syndrome and sepsis (54). Offner et al. (55) further emphasized that the male sex constitutes a significant risk factor for major post-trauma infections. Moreover, in cohorts involving trauma patients with either blunt or penetrating injuries, post-trauma complications such as pneumonia (56, 57), sepsis (58), and multiple organ failure (59) are more prevalent in men. Factors such as the length of ICU stay and ventilator use are influenced by the patient’s age and the severity of the trauma, but they predominantly impact men (60).

While disparities in trauma complications between men and women are well established, the impact of sex on survival after injury remains less clear. Mortality rates stemming from penetrating or blunt trauma, as well as post-trauma infection, exhibit a pronounced male predilection (60–63). While studies delineating mortality disparities across age cohorts manifest certain inconsistencies, discernible trends persist, albeit with variation across investigations (60, 62, 63).

Biological sex differences become apparent in trauma patients, with men producing significantly higher IL-6 levels during the initial 2 days after injury (53). Similar findings have been reported in polytraumatized patients, where men exhibit higher levels of IL-6 and IL-8 compared with women (54). Additionally, men with multiple injuries and those who develop post-trauma sepsis produce increased levels of IL-6, IL-8, and TNF-α (64).

Animal studies further emphasize the existence of inflammatory sexual dimorphism in the context of trauma, with varying survival rates in different species and trauma contexts, emphasizing the complexity of sex-related responses to trauma (65, 66). In experimental mouse trauma models, male macrophages produce higher levels of IL-6 (67, 68).

Burn injuries are another type of trauma with discrepant results regarding complications and survival in humans. Several authors have demonstrated increased length of hospital or ICU stays and higher mortality rates in women (69–72). Cumming et al. (73) identified an association between the male sex and the development of multiple organ dysfunction and severe sepsis following burn trauma. The prognosis may be influenced by the duration of the process, with worse outcomes in men during the acute phase, while chronic inflammation consequences may exacerbate the prognosis in women.

The conflicting outcomes observed in burn trauma studies may stem from variations in the timing of analyses and the involvement of cofactors such as skin loss, fluid depletion, hypovolemic shock, and secondary infections. Additionally, the inconsistencies may arise from the heterogeneous nature of the aggression, incorporating elements like fractures, hematomas, bacterial translocations. Consequently, the comparison between study populations becomes notably challenging.

Surgery itself acts as an inflammatory trigger, yet there is a scarcity of research in this domain. Similarly to the studies on trauma, the presence of confounding factors such as underlying pathology or infectious complications adds complexity to research endeavors in surgery and inflammation.

Among patients who have undergone surgery, men present a higher mortality risk and are more susceptible to complications. In a study involving 512 surgical patients, men demonstrated a higher risk of developing major respiratory complication, with no sex-specific differences regarding the duration of the operation, the length of hospital stay, or mortality rates (74). Similarly, in a study on surgical intensive care patients, the authors observed a higher incidence of severe sepsis or septic shock among men (17), and a large retrospective analysis revealed a higher perioperative morbidity in male surgical patients (75).

Sex-specific cytokine profiles have been identified in surgical patients, revealing an excessive release of TNF-α and diminished levels of IFN-γ in stimulated male peripheral blood mononuclear cells (PBMCs) (76).

There is very limited information on surgery-induced inflammation and mortality in animals. In equine surgical operations for colic, some researchers have reported higher mortality rates for males (77), while others studies have not confirmed these results (78).

TLR2 and TLR4 play a significant role in the recognition of these pathogens and the subsequent release of inflammatory cytokines during sepsis (84, 91, 92). The presence of a specific IRAK-1 variant haplotype, a crucial protein in the TLR2 and TLR4 pathway, is linked to increased nuclear translocation of NF-κB, contributing to a worse prognostic clinical presentation in sepsis (93). Moreover, TLR2 and TLR4 polymorphisms are associated with a higher risk of staphylococcal or gram-negative infections, further underscoring the involvement of TLRs in sepsis (94, 95). TLR2 and TLR4 mRNA upregulation is also described in monocytes from patients with sepsis (96, 97).

Multiple TLRs recognize S. pneumoniae, the most frequent bacteria in CAP: TLR2 recognizes lipoteichoic acid and lipoproteins from the pneumococcal cell wall (91), TLR4 detects pneumolysin (91, 98) and TLR9 is activated through recognition of pneumococcal bacterial DNA which contains unmethylated CpG motifs (89). All three of these receptors regulate the NF-κB pathway to enhance proinflammatory cytokine release (91).

Animal experiments further support the involvement of TLRs in sepsis and pneumococcal lung infection: mice with experimental sepsis exhibit a cytokine pattern dependent on NF-κB and MAPKs (37) and TLR2 and TLR4 knockout (KO) mice display less effective cytokine release compared with wild mice (90).

In murine models of sepsis, TLR2 and TLR4 are upregulated in hepatic and splenic macrophages (90). Similarly, mice with peritonitis show higher expression of TLR2 and TLR4 mRNA in the lungs and liver (99). The administration of endotoxin leads to the upregulation of TLR2 mRNA through TLR4- and MyD88-dependent signaling in alveolar macrophages and endothelial cells (100, 101). This crosstalk between TLR2 and TLR4 is achieved through activated polymorphonuclear neutrophils (PMNs), making their presence a determinant element in the response within TLR pathway (100, 101).

In mice with endothelial cells lacking TLR4, pulmonary neutrophil recruitment is significantly reduced after exposure to LPS, illustrating the importance of alveolar endothelial TLR4 expression in pulmonary neutrophil recruitment during sepsis (102).

In animal experiments simulating pneumococcal lung infection, TLR4 KO mice demonstrate a less vigorous immune response (103, 104). TLR2-deficient mice show decreased release of proinflammatory cytokines (105, 106), and TLR9-deficient mice exhibit weaker lung bacterial clearance compared with wild-type mice (89).

The role of TLRs in viral infections has gained significant attention in the context of the COVID-19 pandemic. Initially, information about TLR recognition of SARS-CoV-2 was extrapolated from data on SARS-CoV-1. Among the TLRs described in SARS-CoV-1 infection, TLR3 and TLR7 are the most prominent, leading to type I IFN expression through the TRIF–IRF3 pathway (83, 107, 108). There is also evidence for MyD88-dependent pathway activation by SARS-CoV-1, such as NF-κB (109, 110). Furthermore, AP-1 activation has been previously described solely in the context of SARS-CoV infections, with the spike and nucleocapsid proteins of the virus identified as the triggering factors (111, 112).

In the context of severe COVID-19 cases in adults involving a massive release of proinflammatory cytokines, numerous studies have emphasized the role of TLRs. Molecular docking investigations have revealed a strong interaction between TLR4 and the spike glycoprotein of SARS-CoV-2. Additionally, the upregulation of TLR4 and its associated pathway components (CD14, MyD88, Mal, TRAF6, IRAK1, and TRIF) have been observed in PBMCs from patients with COVID-19 (113–115). TLR2 can recognize SARS-CoV-2 by interacting with the SARS-CoV-2 E protein; this interaction amplifies intracellular immune pathways, leading to the activation of an immune response against the pathogen (116).

We previously described the relation between endothelial TLR4 and neutrophil recruitment in experimental models simulating bacterial infection (102). An intriguing observation is that COVID-19 in adults is also marked by a swift and substantial influx of neutrophils (117). This is further reflected in the elevated peripheral blood neutrophil count in patients with COVID-19, with the neutrophil-to-lymphocyte ratio (NLR) serving as an indicator of disease severity (40, 117). Nevertheless, the impact of TLRs and sex on neutrophil levels in COVID-19 remains an understudied area (40). Only one study suggests a male predominance in the NLR among patients with COVID-19, which is associated with a more unfavorable prognosis (118).

Animal models have produced similar findings regarding the implication of TLRs in Coronaviridae detection. For SARS-CoV-1, direct evidence points to the implication of TLR4, as TLR4 KO mice are more susceptible to SARS-CoV-1 than wild-type mice, exhibiting higher viral titers (115).

Another virus notorious for eliciting a robust inflammatory response, as well as notable and swift neutrophil recruitment, is RSV (117, 119). RSV activates the NF-κB pathway through TLR2 and TLR4, similarly to bacterial pathogens, to trigger cytokine release and to recruit immune cells into the airways (43). Notably, TLR4 polymorphisms are associated with severe RSV clinical presentations in children (120–123). RSV upregulates TLR4 in airway epithelial cells and monocytes among children with acute bronchiolitis (124, 125). In vitro studies on human peripheral macrophages suggest that TLR4 recognizes the RSV F protein (126), and bronchoalveolar lavage analyses have demonstrated elevated neutrophil levels in children with severe bronchiolitis (127–129). Girls with viral bronchiolitis tend to have higher levels of circulating neutrophils compared with boys (130).

Studies in mice underscore the contributions of TLR2 and TLR4 to RSV recognition, with TLR2 KO mice showing a higher viral load and impaired cytokine mediation (131) and TLR4 KO mice displaying an impaired immune response and reduced virus clearance (132). TLR4 also plays a role in recognizing human metapneumovirus and enhancing the innate immune response against this pathogen (133).

Human cytomegalovirus (HCMV) is detected by both membranous and endosomal TLRs. Glycoproteins on the HCMV surface interact with TLR2 and TLR4, resulting in the activation of the NF-κB pathway and subsequent production of proinflammatory cytokines (134). Furthermore, HCMV nucleic acids are recognized by endosomal TLR3, leading to the release of IFN-α (134). Studies investigating mutations or polymorphisms in TLR3 and TLR9 have indicated an increased risk of CMV infection, underscoring the significant role played by these receptors in the recognition of HCMV (134).

The recognition of the DENV involves activation of both the MyD88 and IRF-3 or IRF-5 pathways, dependent on the specific viral components engaged in the interaction with the host’s immune response (135). Specifically, DENV2 triggers TLR3, TLR7, and TLR8, resulting in a robust induction of IL-8 and IFN-α (136, 137). Additionally, the DENV NS1 protein induces signaling pathways associated with TLR2, TLR6, and TLR4, leading to subsequent proinflammatory cytokine production (138, 139). Individuals with TLR4 polymorphisms exhibit an increased susceptibility to DENV infection (140) and patients with dengue hemorrhagic fever demonstrate elevated TLR2 expression in comparison to those with dengue fever (141). In animal models of experimental dengue infection, mice lacking TLR6 exhibit improved survival rates following exposure to DENV2 and NS1, in contrast to wild-type mice (139). In macaques, dengue virus recognition is described through TLR3, TLR7, and TLR8 (142).

As mentioned above, influenza A exhibits a different pattern, with women being more susceptible to an increased risk of severe clinical presentations (47) and higher IFN-γ levels compared with men (44, 48, 49). The influenza virus primarily activates TLR7 and the IRF3 pathway (143) rather than the TLR4 or MyD88-dependent pathways. In rodent models of influenza infection, TRL3- and TLR7-deficient mice are unable to control viral replication and succumb to the disease (144). TLR4 contribution was not demonstrated in TLR4 KO mice with influenza infection, thereby affirming the predominant involvement of TLR3 and TLR7 activation in response to influenza virus (132).

There are no studies focusing on the impact of surgical procedures on the activation of TLR pathways. In many surgical pathologies, TLRs are already stimulated by pathogens or DAMPs (145). As in humans, the literature available on the interaction between surgery and TLR responses in animals is limited. However, a notable finding comes from experiments involving mice subjected to sternotomy and treated with a TLR9 antagonist. In this context, a decrease in IL-6 production is observed, highlighting the potential significance of the TLR9 pathway in modulating the inflammatory response elicited by surgical procedures (146).

The precise involvement of TLRs in trauma remains a topic of ongoing investigation, with conflicting findings in the literature. Trauma patients with an ISS (injury severity score) over 12 display heightened expression of TLR2 and TLR4 on monocytes (147). However, in patients with an ISS exceeding 25, TLR4 expression on monocytes decreases, and TLR2 expression is similar to healthy subjects (148). Some studies report unaltered TLR4 but reduced TLR2 expression in patients with an ISS greater than 21 (149). These findings are based on limited populations, emphasizing the need to expand these studies before drawing definitive conclusions. Furthermore, thoughtful consideration should be given to the potential limitation in TLR2 and TLR4 availability resulting from their excessive engagement in the context of trauma.

Trauma patients exhibit higher serum levels of IL-6 and IL-10 (147). Previous studies have established a discernible correlation between IL-6 levels and ISS within the initial 72 hours of hospitalization (150). TLR2, -4 and -9 activation results in trauma patients results in an impaired proinflammatory response, as evidenced by lower TNF and IL-6 levels (148, 149) and increased release of IL-10 (148).

Findings from a murine model indicate that TLR4 plays a crucial role in neutrophil accumulation and well as increased TNF-α production (denoted by increased mRNA and protein levels) following experimental hemorrhage (151). Hemorrhage in mice leads to increased upregulation of p38, ERK1/2, and c-Jun N-terminal kinase (JNK) in Kupffer cells, as described by Thobe et al. (152). Furthermore, the release of proinflammatory cytokines mediated by TLR2 and TLR4 is modulated through the p38, ERK1/2, and JNK pathways (152). The inflammatory response after lung injury in mice appears to be TLR9-mediated, as TLR9-deficient mice exhibit reduced proinflammatory cytokine release (153). TLR9-dependent TNF-α and IL-6 production has been shown to rely on JNK (152).

TLRs have also been implicated in burn injuries: The levels of TLR2, TLR4, and TLR9 on DCs are higher in burn patients compared with healthy volunteers. Additionally, TLR2 protein expression is associated with the survival prospects of individuals affected by burn injuries (154). However, in the specific context of burn trauma, hemodynamic and infectious cofactors impede a thorough analysis of the specific TLR implication in thermal injuries. As highlighted in the above studies on TLR analysis in trauma patients, the constrained sample size underscores the need for further investigations in this field.

In murine models, TLR function is impaired in the context of burn injuries. Macrophages from burned mice show reduced expression of TLR3 and TLR9 mRNA compared with macrophages from their healthy counterparts (155). DCs from burned mice have lower TLR9 mRNA expression, resulting in an altered cytokine release profile characterized by an anti-inflammatory response, including elevated IL-10 levels and reduced production of IL-6, TNF-α, and IL-12p70 (156).

There have been diverse results regarding TLR2 and TLR4 expression. An in vitro study on neutrophils from healthy young adults stimulated with either LPS or IFN-γ revealed higher TLR4 expression in men (157). Conversely, higher TLR2 expression is reported in monocytes from healthy women (76). However, other researchers have not identified any sex difference in TLR4 or TLR2 expression on human immune cells after exposure to LPS (76, 158).

In some studies exploring the potential influence of sex on TLR responses, researchers have analyzed cytokine release subsequent to TLR activation. In vitro stimulation of TLR4 and TLR2 by LPS or zymosan, respectively, results in augmented proinflammatory cytokine release in whole blood or isolated leukocyte populations from men (157, 159–162). Furthermore, after LPS stimulation, men exhibit a higher percentage of IL-12-, IL-1β-, and TNF-α-producing monocytes compared with women (163).

As discussed previously, men tend to produce predominantly proinflammatory cytokines, whereas women primarily release cytokines from the IL-10 family. This distinctive sex-related pattern is further corroborated through TLR2 and TLR4 activation. When subject to whole blood endotoxin stimulation, women demonstrate elevated levels of IL-10, relative to the monocyte concentration, enhancing their ability to regulate the immune response effectively (164). Indeed, IL-10 plays an essential role in maintaining the integrity and homeostasis of the cellular environment during inflammation (165).

Regarding the downstream proteins within the TLR2–TLR4 pathway, male neutrophils present greater activation of ERK, p38, JNK, and Akt upon LPS stimulation. However, there are no discernible sex differences in either IκBα phosphorylation or degradation subsequent to endotoxin exposure (157).

The above studies reveal divergent patterns in the sex-related expression of TLR2 and TLR4 in human. However, activation through ligands primarily elicits an enhanced response in men, with increased cytokine release and higher TLR2- and TLR4-associated proteins. These differences appear to stem from the core pathway, specifically involving the proteins associated with TLRs and the mechanisms governing cytokine release, rather than the receptors themselves.

We previously described the relation between endothelial TLR4 and neutrophil recruitment in bacterial infection (102) or viral infections characterized by a significant recruitment of neutrophils, such as COVID-19 (117) and RSV bronchiolitis (43, 117, 119). The predominant function of TLR2 and TLR4 in men offers a promising avenue of research to identify the etiology of worse clinical outcomes and heightened inflammatory responses observed in men.

Research on TLR2 and TLR4 mRNA and protein expression in animal models has yielded inconsistent results. At basal state, male mice express higher levels of TLR2, while higher TLR4 levels are registered on macrophages from female mice (166). Conversely, certain studies suggest that while there are no discernible sex differences in TLR4 mRNA expression under baseline conditions, male murine macrophages exhibit higher levels of TLR4 protein on their cell surfaces (167).

These contradictory results also extend to stimulated conditions in animals. Stimulated female rodent peritoneal leukocytes show increased TLR2 mRNA and TLR4 mRNA levels (168). However, a communication by Marriot et al. (167) suggests that stimulated murine macrophages do not exhibit a sex difference in TLR4 mRNA expression. In an infectious model involving rodents infected with coxsackievirus, female mice demonstrate improved survival rates, which correspond to higher TLR2 expression on lymphocytes (169). Females also display lower TLR4 expression on lymphocytes, monocytes, and DCs (169). In the same model, male mice display an increase in TLR2 expression on monocytes and DCs (169). Furthermore, after trauma and hemorrhagic shock, and also following LPS stimulation, mouse macrophages do not display sex-dependent TLR4 expression on their surface (170).

Interestingly, when analyzing cytokine response to LPS stimulation, male subjects display elevated IL-6 levels (167, 168). Moreover, male-derived macrophages exposed to LPS exhibit higher levels of IL-1β (167). Once again, similarly to human studies, it appears that sex differences are more evident within the context of the TLR2 and TLR4 pathways than in the receptors themselves.

Limited information is available regarding the TLR3 sex bias in infectious diseases. In human studies, researchers have assessed activation of the TLR3 pathway by measuring cytokine release after stimulating PBMCs with polyinosinic:polycytidylic acid (poly I:C). They have registered significant sex differences only for TNF-α, specifically higher levels in male PBMCs (171, 172). Stimulation with herpes simplex virus 1 (HSV1), a double-stranded DNA virus, induces higher IL-10 production in men, although it is essential to note that this virus also engages TLR9 (172).

Findings from animal experiments indicate greater TLR3 mRNA expression in peritoneal leukocytes from female mice, although the authors did not investigate protein expression under infectious conditions (168). In virus challenge models involving Seoul virus, female rats exhibit lower TLR3 expression compared with male rats (173).

Higher expression of TLR7 has been registered in women (174). As described above, TLR7 activates the type I IFN signaling pathway. Consequently, increased levels of type I IFN are observed in immune cells from adult and adolescent women following exposure to TLR7 ligands (175, 176). In patients with COVID-19, women demonstrate elevated production of IFN-α2 (2).

Stimulation of TLR7 and TLR8 leads to amplified production of both type I and type II IFNs and decreased levels of IL-1β, IL-6, IL-8, IL-10, and TNF-α in female PBMCs (160, 172, 176, 177). In whole blood samples, resiquimod induces significant sex differences only in IL-1β, IL-6, and TNF-α, with higher production in men (160). Interestingly, HCMV suppresses the response to TLR7/8 stimulation specifically in women (178). In rats, greater TLR7 expression occurs in females following viral exposure (173).

Certain viruses, such as influenza mainly activates IRF3 pathway through TLR7 triggering (143). This leads to a distinct pattern where women exhibit greater susceptibility to an increased risk of severe clinical presentations (47) and elevated IFN-γ compared with men (44, 48, 49). The more pronounced TLR7 activation in women likely serves as an explanation for the differing sex-specific patterns in inflammatory responses and clinical outcomes in the case of these pathogens.

In most studies, stimulation of human DCs with CpG, a TLR9 ligand, results in no sex bias in IFNα production (175, 177). However, a recent investigation using CpG-A indicates increased type I and II IFN expression in PBMCs obtained from blood samples from women (176).

When considering animal models, mouse cytomegalovirus (MCMV) infection leads to an upregulation of TLR9 expression in male immune cells compared with female cells. In MCMV-infected wild-type mice, males exhibit higher neutrophil and DC infiltration. However, in TLR9 KO mice, there are no sex differences following infection (179).

Under conditions of bacterial stimulation, exposure to exogenous or naturally occurring estradiol tends to have an anti-inflammatory effect, resulting in decreased production of IL-1β, IL-6, TNF-α, and GM-CSF, while increasing the release of IL-10, IL-12, IL-23, and IL-27 (180). In vitro, human PBMCs stimulated with LPS and estradiol, show suppressed TNF-α production (159).

On the other hand, a review from Bouman et al. (181), presents contentious evidence regarding the impact of estrogens and progesterone on IL-1β, IL-6, TNF-α, and IL-12 expression. Additionally, a study involving menopausal women who underwent hormone replacement therapy revealed no significant effects on IL-6, IL-1ra, IL-1α, and TNF-α production (182), while Another investigation focusing on human ectocervical epithelial cells demonstrated that following LPS stimulation, estradiol treatment increases the secretion of IL-1β, IL-6, IL-8, and IFN-γ compared with untreated cells (183). At first sight, the impact of estrogen and progesterone on the expression of inflammatory cytokines appears to be inconsistent among different studies ( Figures 3 , 4 ).

A study investigating the impact of sex on stimulated human cord blood mononuclear cells, reveals that estradiol and progesterone decrease TNF and IL-6 protein and gene expression (184). The authors assessed TLR2 and TLR4 mRNA expression, as well as the protein levels of components within the NF-κB and MAPK pathways. Estradiol and progesterone do not influence TLR2 or TLR4 mRNA expression or the MAPK pathway, but do mediate cytokine release by inhibiting the phosphorylation of IκBα and increasing NFKBIA mRNA levels (184). The study concluded that the absence of phosphorylation prevents the ubiquitination and degradation of the IκBα protein, while the elevated mRNA levels suggest a potential increase in IκBα transcription. Under these circumstances, IκBα is unable to release the NF-κB p65 subunit, leading to inhibition of the NF-κB pathway (184). This finding could account for the observed difference in NF-κB dependent cytokine release regulation between women and men, with women showing more regulated release and men displaying higher levels of pro-inflammatory cytokines.

Jitprasertwong et al. (185) confirmed that exposure to estradiol and progesterone blocks the NF-κB pathway but does not affect TLR4 gene and protein expression or activation of MAPKs (phosphorylated forms of p38, ERK1/2, and JNK). The same authors also reported TLR2 mRNA and protein downregulation, as well as reduced CD14 protein expression on stimulated human monocytes exposed to estradiol and progesterone (185).

Reduced TLR2 mRNA expression was also observed after stimulation with S. aureus in male monocytes treated with 17β-estradiol and monocytes from women during their fertile period (180). However, conflicting findings arise again for these receptors; while some studies indicate no influence on TLR2 mRNA (186), others demonstrate its upregulation in whole blood exposed to 17β-estradiol or progesterone (norethisterone), as well as in THP-1 cells treated with 17β-estradiol (187, 188). When female PBMCs are treated with progesterone, it results in the inhibition of both responsiveness and TLR4 expression (189).

Relative to other TLR pathway–related proteins, comparison of the gene expression profiles of women during their fertile period and men has revealed several noteworthy distinctions. In stimulated female monocytes TNF, MAPK8, and other genes are downregulated. Likewise, a comparison between male immune cells exposed to 17β-estradiol and their untreated but stimulated counterparts demonstrated that estradiol negatively regulates the NFKB1, IRAK2, IL1B, IL1A, IL12A, IKBKB, and BTK genes, but does not affect the IRAK1 gene (180). Stimulated female PBMCs treated with progesterone show markedly reduced MYD88 and NFKB1 mRNA levels (189).

To delve deeper into the influence of sex steroids on immune responses, several studies have examined TLR2 and TLR4 pathways modulation in women, across the menstrual cycle or during pregnancy ( Figure 5 ). According to some researchers, female hormones impede relative TLR2, CD14, BTK, and TNF gene expression in human peripheral blood monocyte, while higher IL-12 levers are observed in the presence of these hormones (180). On the other hand, higher cytokine responsiveness to TLR2 activation is observed during follicular phase when estrogen is predominant, and then decreases during the luteal phase marked by progesterone presence (190). Some publications suggest that TLR4 expression remains consistent in women throughout the menstrual cycle (191), while others describe increased TLR4 responsiveness during the early luteal phase, which then decreases during the late luteal phase (190). According to Ziegler et al. (192), at the beginning of pregnancy, stimulation of TLR4 in PBMCs induces the release of TNF-α, which subsequently decreases as the pregnancy progresses.

Overall, the abovementioned studies have yield highly contrasting outcomes concerning the expression and activation of TLR2 and TLR4 following exposure to estrogens and progesterone ( Figures 3 - 5 ). The unclear influence of these steroids challenges their role as the primary etiology of sex differences in TLR2- and TLR4-mediate inflammatory responses in humans.

In animal models, estradiol enhances the expression of TLR4 on rodent macrophages (193). In addition, ovariectomy reduces the expression of TLR2 and TLR4 in leukocytes and protein expression of TLR2 and TLR4 on macrophages (168). On the other hand, Souza et al. (180) reported that murine peritoneal macrophages from ovariectomized females express higher TLR2 mRNA levels than wild-type females. Moreover, treatment of ovariectomized females or males with estradiol decreases TLR2 expression. In mouse plasmacytoid dendritic cells (pDCs), progesterone exposure decreases the IL-12p40 induction through TLR4 (194). These findings highlight the complex interplay between sex hormones and TLR expression in animals.

Estradiol increases TLR8 expression, both at the RNA and protein levels, in PBMCs from healthy premenopausal women. Moreover, it enhances TLR7 gene expression in PBMCs from healthy premenopausal females and pDCs from postmenopausal women (186, 195). However, in monocytes, TLR7 and TLR8 gene expression does not vary between fertile women and men or between cells treated compared to those not treated with estradiol ( Figures 3 , 4 ) (180).

The production of IFN-a, which relies on TLR7 activation, is reduced in PBMCs from women in the first trimester of pregnancy; however, there is an increase in stimulated pDCs during pregnancy (1, 192). Notably, the menstrual cycle does not affect TLR7 activation (190). In contrast, a decrease in responsiveness is described after TLR8 activation during the luteal phase (190). Remarkably, higher TLR7-induced IFN levels in pDCs from women compared with men (196) occur even before puberty ( Figures 3 – 5 ) (197), prompting further discussion about the actual role of sex steroids in immune dimorphism and cytokine release.

Studies investigating the influence of hormonal contraception on TLR7/8 signaling have yielded mixed results. Some have described no significant difference in DC activation in women receiving depot medroxyprogesterone acetate (DMPA) or NuvaRing compared with those not using contraception (198, 199). Other studies suggest an inhibitory effect of medroxyprogesterone acetate on the production of IFN-α and TNF-α by TLR7–TLR8 activated pDCs (200). Interestingly, the presence of estrogen during the fertile period downregulates the IRF1, IFNG, IFNB1, and IFNA1 genes in monocytes, all of which are involved in TLR7/8 signaling (180).

In mice exposed to estradiol, there is an increase in TLR8 mRNA in various tissues, including the spleen, thymus, bone marrow, and lymph nodes (186). Mouse DCs exposed to estradiol display increased TNF-α release following TLR7 and TLR9 activation (195). Interestingly, ablation of the ESR1 gene (which encodes estrogen receptor α) in DCs abolishes the TLR7-mediated IFN response (195). In murine DCs, pre-treatment with progesterone impairs the ability to release TNF-α and IL-1β, as TNF gene expression is also disturbed in a dose-dependent manner (201). On the contrary, progesterone exposure does not affect the production of IL-10 (201). However, progesterone exerts a negative influence on IL-12p40 induction through TLR 7 stimulation in mouse pDCs ( Figures 3 , 4 ) (194).

Researchers have reported diverse effects of estrogens on TLR9. Higher TLR9 gene expression is registered in PBMCs exposed to estradiol (186). In DCs, the presence of estradiol induces higher amounts of cytokine release upon TLR9 activation (195). Conversely, the use of hormonal contraception (such as DMPA or NuvaRing) or in vitro progesterone treatment reduce the capacity of pDCs to produce IFN-α, TNF-α, or IL-12p40 in response to TLR9 agonists (194, 199, 200). In rodents, DMPA hampers the production of IFN-α by pDCs following TLR9 activation or viral infection ( Figures 3 , 4 ) (194).

There is limited information available on the influence of sex hormones on TLR3 expression and activation in humans. PBMCs treated with estradiol show enhanced TLR3 mRNA expression (186), while there are no differences in monocytes (180). In endometrial epithelial cells, estradiol does not affect TLR3 gene or protein expression, but suppresses the release of IL-6 and IL-8 upon TLR3 stimulation with poly I:C. Lesmeister et al. (202) suggest that these results may be attributed to estradiol modulating the function rather than the quantity of this receptor. Nonetheless, no variations in TLR3-induced cytokines or TLR3 mRNA expression have been identified throughout the menstrual cycle (190, 203). In mouse models, ovariectomy decreases TLR3 expression in leukocytes and TLR3 protein expression on macrophages ( Figures 3 – 5 ) (168).

There is also scare literature regarding whether there is a TLR5 sex bias. In monocytes treated with 17-β estradiol, there are no differences in TLR5 mRNA expression (180). Concerning TLR5-induced cytokines during the menstrual cycle, an increase in IL-1β and TNF-α release has been described from the follicular to the early luteal phase, while a decrease in IL-6 has been noted during the luteal phase ( Figures 3 – 5 ) (190).